Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies
Ahn, Myung‐Ju, Tsai, Chun‐Ming, Shepherd, Frances A., Bazhenova, Lyudmila, Sequist, Lecia V., Hida, Toyoaki, Yang, James C. H., Ramalingam, Suresh S., Mitsudomi, Tetsuya, Jänne, Pasi A., Mann, Helen, Cantarini, Mireille, Goss, Glenwood
Published in Cancer (15.03.2019)
Published in Cancer (15.03.2019)
Get full text
Journal Article
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
Yang, James C-H, Prof, Sequist, Lecia V, MD, Geater, Sarayut Lucien, MD, Tsai, Chun-Ming, Prof, Mok, Tony Shu Kam, Prof, Schuler, Martin, Prof, Yamamoto, Nobuyuki, Prof, Yu, Chong-Jen, Prof, Ou, Sai-Hong I, MD, Zhou, Caicun, Prof, Massey, Daniel, MSc, Zazulina, Victoria, MD, Wu, Yi-Long, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
SEQUIST, Lecia V, YANG, James Chih-Hsin, SU, Wu-Chou, BENNOUNA, Jaafar, KATO, Terufumi, GORBUNOVA, Vera, KI HYEONG LEE, SHAH, Riyaz, MASSEY, Dan, ZAZULINA, Victoria, SHAHIDI, Mehdi, SCHULER, Martin, YAMAMOTO, Nobuyuki, O'BYRNE, Kenneth, HIRSH, Vera, MOK, Tony, GEATER, Sarayut Lucien, ORLOV, Sergey, TSAI, Chun-Ming, BOYER, Michael
Published in Journal of clinical oncology (20.09.2013)
Published in Journal of clinical oncology (20.09.2013)
Get full text
Journal Article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer
Papadimitrakopoulou, Vassiliki A., Han, Ji‐Youn, Ahn, Myung‐Ju, Ramalingam, Suresh S., Delmonte, Angelo, Hsia, Te‐Chun, Laskin, Janessa, Kim, Sang‐We, He, Yong, Tsai, Chun‐Ming, Hida, Toyoaki, Maemondo, Makoto, Kato, Terufumi, Jenkins, Suzanne, Patel, Sabina, Huang, Xiangning, Laus, Gianluca, Markovets, Aleksandra, Thress, Kenneth S., Wu, Yi‐Long, Mok, Tony
Published in Cancer (15.01.2020)
Published in Cancer (15.01.2020)
Get full text
Journal Article
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Soria, Jean-Charles, Prof, Tan, Daniel S W, MD, Chiari, Rita, MD, Wu, Yi-Long, Prof, Paz-Ares, Luis, Prof, Wolf, Juergen, Prof, Geater, Sarayut L, MD, Orlov, Sergey, Prof, Cortinovis, Diego, MD, Yu, Chong-Jen, Prof, Hochmair, Maximillian, MD, Cortot, Alexis B, Prof, Tsai, Chun-Ming, Prof, Moro-Sibilot, Denis, MD, Campelo, Rosario G, MD, McCulloch, Tracey, MSc, Sen, Paramita, PhD, Dugan, Margaret, MD, Pantano, Serafino, PhD, Branle, Fabrice, MD, Massacesi, Cristian, MD, de Castro, Gilberto, MD
Published in The Lancet (British edition) (04.03.2017)
Published in The Lancet (British edition) (04.03.2017)
Get full text
Journal Article
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Park, Keunchil, Prof, Tan, Eng-Huat, MD, O'Byrne, Ken, Prof, Zhang, Li, Prof, Boyer, Michael, Prof, Mok, Tony, Prof, Hirsh, Vera, Prof, Yang, James Chih-Hsin, Prof, Lee, Ki Hyeong, MD, Lu, Shun, Prof, Shi, Yuankai, MD, Kim, Sang-We, MD, Laskin, Janessa, MD, Kim, Dong-Wan, Prof, Arvis, Catherine Dubos, MD, Kölbeck, Karl, MD, Laurie, Scott A, MD, Tsai, Chun-Ming, Prof, Shahidi, Mehdi, MD, Kim, Miyoung, MD, Massey, Dan, PhD, Zazulina, Victoria, MD, Paz-Ares, Luis, MD
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
Yang, James Chih-Hsin, Prof, Wu, Yi-Long, Prof, Schuler, Martin, Prof, Sebastian, Martin, MD, Popat, Sanjay, FRCP, Yamamoto, Nobuyuki, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, O'Byrne, Kenneth, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Geater, Sarayut L, MD, Lee, Kye Young, Prof, Tsai, Chun-Ming, Prof, Gorbunova, Vera, Prof, Hirsh, Vera, Prof, Bennouna, Jaafar, Prof, Orlov, Sergey, Prof, Mok, Tony, Prof, Boyer, Michael, Prof, Su, Wu-Chou, Prof, Lee, Ki Hyeong, Prof, Kato, Terufumi, MD, Massey, Dan, MSc, Shahidi, Mehdi, MD, Zazulina, Victoria, MD, Sequist, Lecia V, MD
Published in The lancet oncology (01.02.2015)
Published in The lancet oncology (01.02.2015)
Get full text
Journal Article
Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
CHEE KHOON LEE, BROWN, Chris, JEMELA ANNE OSORIO SANCHEZ, VU VAN VU, JOSEPH SIU KIE AU, INOUE, Akira, SIOW MING LEE, GEBSKI, Val, YANG, James Chih-Hsin, GRALLA, Richard J, HIRSH, Vera, THONGPRASERT, Sumitra, TSAI, Chun-Ming, ENG HUAT TAN, HO, James Chung-Man, DATONG CHU, ZAATAR, Adel
Published in JNCI : Journal of the National Cancer Institute (01.05.2013)
Published in JNCI : Journal of the National Cancer Institute (01.05.2013)
Get full text
Journal Article
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study
Crinò, Lucio, Prof, Dansin, Eric, MD, Garrido, Pilar, MD, Griesinger, Frank, Prof, Laskin, Janessa, MD, Pavlakis, Nick, MBBS, Stroiakovski, Daniel, Prof, Thatcher, Nick, Prof, Tsai, Chun-Ming, Prof, Wu, Yi-long, Prof, Zhou, Caicun, Prof
Published in The lancet oncology (01.08.2010)
Published in The lancet oncology (01.08.2010)
Get full text
Journal Article
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Yang, James Chih-Hsin, Prof, Shih, Jin-Yuan, MD, Su, Wu-Chou, Prof, Hsia, Te-Chun, MD, Tsai, Chun-Ming, Prof, Ou, Sai-Hong Ignatius, MD, Yu, Chung-Jen, Prof, Chang, Gee-Chen, MD, Ho, Ching-Liang, MD, Sequist, Lecia V, MD, Dudek, Arkadiusz Z, MD, Shahidi, Mehdi, MD, Cong, Xiuyu Julie, PhD, Lorence, Robert M, MD, Yang, Pan-Chyr, Prof, Miller, Vincent A, Dr
Published in The lancet oncology (01.05.2012)
Published in The lancet oncology (01.05.2012)
Get full text
Journal Article
Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
NATALE, Ronald B, THONGPRASERT, Sumitra, BARLESI, Fabrice, LANGMUIR, Peter, GOGOV, Sven, ROWBOTTOM, Jacqui A, GOSS, Glenwood D, GRECO, F. Anthony, THOMAS, Michael, TSAI, Chun-Ming, SUNPAWERAVONG, Patrapim, FERRY, David, MULATERO, Clive, WHORF, Robert, THOMPSON, Joyce
Published in Journal of clinical oncology (10.03.2011)
Published in Journal of clinical oncology (10.03.2011)
Get full text
Journal Article
A comprehensive quality improvement model: integrating internal and external information
Tsai, Ming-Chun, Lin, Shu-Ping, Cheng, Ching-Chan
Published in Total quality management & business excellence (03.04.2022)
Published in Total quality management & business excellence (03.04.2022)
Get full text
Journal Article
Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs
Ho, Hsiang-Ling, Wang, Fang-Yu, Chiang, Chi-Lu, Tsai, Chun-Ming, Chiu, Chao-Hua, Chou, Teh-Ying
Published in International journal of molecular sciences (26.09.2022)
Published in International journal of molecular sciences (26.09.2022)
Get full text
Journal Article
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer
Ho, Hsiang-Ling, Jiang, Yuqiu, Chiang, Chi-Lu, Karwowska, Sylwia, Yerram, Ranga, Sharma, Keerti, Scudder, Sidney, Chiu, Chao-Hua, Tsai, Chun-Ming, Palma, John F, Sharma, Abha, Chou, Teh-Ying
Published in PloS one (28.04.2022)
Published in PloS one (28.04.2022)
Get full text
Journal Article
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
Cho, Byoung Chul, Loong, Herbert H F, Tsai, Chun-Ming, Teo, Man Lung P, Kim, Hye Ryun, Lim, Sun Min, Jain, Suyog, Olsen, Steve, Park, Keunchil
Published in Current oncology (Toronto) (21.03.2022)
Published in Current oncology (Toronto) (21.03.2022)
Get full text
Journal Article
The effects of pad geometry and material properties on the biomechanical effectiveness of 26 commercially available hip protectors
Laing, Andrew C, Feldman, Fabio, Jalili, Mona, Tsai, Chun Ming (Jimmy), Robinovitch, Stephen N
Published in Journal of biomechanics (13.10.2011)
Published in Journal of biomechanics (13.10.2011)
Get full text
Journal Article